Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $429,300 - $506,777
-4,290 Reduced 60.24%
2,832 $322,000
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $954,416 - $1.07 Million
-9,475 Reduced 57.09%
7,122 $740,000
Q1 2024

May 06, 2024

BUY
$109.52 - $120.96 $1.82 Million - $2.01 Million
16,597 New
16,597 $1.89 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $1.85 Million - $2.22 Million
19,397 New
19,397 $1.88 Million
Q4 2021

Jan 20, 2022

SELL
$115.53 - $141.46 $1.43 Million - $1.75 Million
-12,351 Closed
0 $0
Q3 2021

Oct 21, 2021

BUY
$116.66 - $129.06 $1.44 Million - $1.59 Million
12,351 New
12,351 $1.45 Million
Q2 2021

Jul 28, 2021

SELL
$105.79 - $124.53 $2.16 Million - $2.54 Million
-20,398 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$108.84 - $128.23 $2.22 Million - $2.62 Million
20,398 New
20,398 $2.46 Million
Q2 2020

Jul 29, 2020

SELL
$76.57 - $98.0 $597,246 - $764,400
-7,800 Closed
0 $0
Q1 2020

Apr 17, 2020

SELL
$62.82 - $91.86 $552,564 - $808,000
-8,796 Reduced 53.0%
7,800 $618,000
Q4 2019

Jan 16, 2020

SELL
$78.51 - $87.4 $196,589 - $218,849
-2,504 Reduced 13.11%
16,596 $1.44 Million
Q3 2019

Oct 31, 2019

BUY
$81.84 - $88.74 $1.29 Million - $1.4 Million
15,800 Added 478.79%
19,100 $1.55 Million
Q2 2019

Aug 08, 2019

SELL
$72.88 - $85.0 $792,497 - $924,290
-10,874 Reduced 76.72%
3,300 $290,000
Q1 2019

Apr 15, 2019

BUY
$66.22 - $80.06 $938,602 - $1.13 Million
14,174 New
14,174 $1.12 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $1.69 Million - $1.87 Million
-29,438 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $1.66 Million - $1.87 Million
29,438 New
29,438 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $230B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sciencast Management LP Portfolio

Follow Sciencast Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sciencast Management LP with notifications on news.